Banco Santander S.A. decreased its stake in UnitedHealth Group Incorporated by 24.5% during the third quarter, selling 20,791 shares and retaining 64,146 shares valued at approximately $22.15 million. Despite this reduction and recent price target trims by several firms due to near-term headwinds like weak guidance, analysts generally maintain a “Moderate Buy” rating for UnitedHealth. The company faces challenges from surging medical costs but offers a 3.1% dividend yield and reported strong quarterly revenue of $113.73 billion.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Banco Santander S.A. Reduces Holdings in UnitedHealth Group Incorporated $UNH
Banco Santander S.A. decreased its stake in UnitedHealth Group Incorporated by 24.5% during the third quarter, selling 20,791 shares and retaining 64,146 shares valued at approximately $22.15 million. Despite this reduction and recent price target trims by several firms due to near-term headwinds like weak guidance, analysts generally maintain a “Moderate Buy” rating for UnitedHealth. The company faces challenges from surging medical costs but offers a 3.1% dividend yield and reported strong quarterly revenue of $113.73 billion.